Patents Assigned to Queen Elizabeth Hospital
  • Patent number: 11369769
    Abstract: An anesthetic administration device comprising an infusion device, which is in fluid connection with a regional anesthetic needle by means of a feed tube. The infusion device comprises one or more anesthetic flow devices capable of triggering forward flow, and optionally backward flow, of the local anesthetic through the regional anesthetic needle. Forward, and optionally backward flow, of the local anesthetic through the regional anesthetic needle is controlled by a controller that comprises one or more actuator switches. The one or more actuator switches are positioned on the device 1 such that they may be operated by hand.
    Type: Grant
    Filed: November 27, 2019
    Date of Patent: June 28, 2022
    Assignee: The Queen Elizabeth Hospital King's Lynn NHS Foundation Trust
    Inventors: Peter Jeffrey Young, Joseph Joachim Carter, Emad Eldin Fahmy Fawzy, John Edward Gibson
  • Patent number: 11129935
    Abstract: A regional anaesthesia injection apparatus comprising an injection volume determiner. The apparatus configured to determine a volume of a regional anaesthetic injection into a target tissue; an injection pressure determiner configured to determine a pressure of the injection; and a controller coupled to the injection volume determiner and to the injection pressure determiner and configured to provide an injection signal to control injection of fluid into the target tissue based on the determined pressure and the determined volume.
    Type: Grant
    Filed: September 23, 2019
    Date of Patent: September 28, 2021
    Assignee: The Queen Elizabeth Hospital King's Lynn NHS Foundation Trust
    Inventors: Peter Jeffrey Young, Joseph Joachim Carter, Emad Eldin Fahmy Fawzy, John Edward Gibson
  • Patent number: 10525229
    Abstract: An anesthetic administration device comprising an infusion device, which is in fluid connection with a regional anesthetic needle by means of a feed tube. The infusion device comprises one or more anesthetic flow devices capable of triggering forward flow, and optionally backward flow, of the local anesthetic through the regional anesthetic needle. Forward, and optionally backward flow, of the local anesthetic through the regional anesthetic needle is controlled by a controller that comprises one or more actuator switches. The one or more actuator switches are positioned on the device 1 such that they may be operated by hand.
    Type: Grant
    Filed: September 17, 2018
    Date of Patent: January 7, 2020
    Assignee: The Queen Elizabeth Hospital King's Lynn NHS Foundation Trust
    Inventors: Peter Jeffrey Young, Joseph Joachim Carter, Emad Eldin Fahmy Fawzy, John Edward Gibson
  • Patent number: 10463829
    Abstract: A regional anesthesia injection apparatus comprising an injection volume determiner. The apparatus configured to determine a volume of a regional anesthetic injection into a target tissue; an injection pressure determiner configured to determine a pressure of the injection; and a controller coupled to the injection volume determiner and to the injection pressure determiner and configured to provide an injection signal to control injection of fluid into the target tissue based on the determined pressure and the determined volume.
    Type: Grant
    Filed: May 29, 2015
    Date of Patent: November 5, 2019
    Assignee: The Queen Elizabeth Hospital King's Lynn NHS Foundation Trust
    Inventors: Peter Jeffrey Young, Joseph Joachim Carter, Emad Eldin Fahmy Fawzy, John Edward Gibson
  • Patent number: 10076630
    Abstract: An anesthetic administration device comprising an infusion device, which is in fluid connection with a regional anesthetic needle by means of a feed tube. The infusion device comprises one or more anesthetic flow devices capable of triggering forward flow, and optionally backward flow, of the local anesthetic through the regional anesthetic needle. Forward, and optionally backward flow, of the local anesthetic through the regional anesthetic needle is controlled by a controller that comprises one or more actuator switches. The one or more actuator switches are positioned on the device such that they may be operated by hand.
    Type: Grant
    Filed: April 24, 2013
    Date of Patent: September 18, 2018
    Assignee: The Queen Elizabeth Hospital King's Lynn NHS Foundation Trust
    Inventors: Peter Jeffrey Young, Joseph Joachim Carter, Emad Eldin Fahmy Fawzy, John Edward Gibson
  • Patent number: 8986262
    Abstract: A sampling connector for use in sampling a body fluid such as arterial blood or cerebrospinal fluid. The sampling connector comprises at least two apertures in fluid communication via a fluid flow conduit and a one-way valve (14) disposed to allow fluid flow from the first aperture, through the fluid flow conduit and out of the second aperture, but not to allow fluid to flow into the second aperture and through the fluid flow conduit to the first aperture. In use, the sampling connector is connected to a body cavity to enable the sampling of a body fluid by withdrawal of the body fluid through the first aperture, and to prevent the introduction of a separate fluid to the body cavity. The first aperture can be within a male end and the second aperture can be within a female end or vice versa. A sampling device comprising a sampling connector according to the present invention and use of the sampling connector and/or sampling device is also claimed.
    Type: Grant
    Filed: March 25, 2009
    Date of Patent: March 24, 2015
    Assignee: The Queen Elizabeth Hospital King's Lynn NHS Trust
    Inventors: Peter Jeffrey Young, Joseph Joachim Carter
  • Patent number: 8014952
    Abstract: Certain biomarkers and biomarker combinations are useful in a qualifying lung cancer status in a subject. A diagnostic methodology employing these biomarkers and combinations can detect whether a subject has lung cancer.
    Type: Grant
    Filed: December 16, 2003
    Date of Patent: September 6, 2011
    Assignees: Queen Elizabeth Hospital, Vermillion, Inc.
    Inventors: Timothy Tak Chun Yip, Chi Shing Cho, Siu Kie Au, Tai-Tung Yip, Christine Yip, Victor Yip
  • Patent number: 7722866
    Abstract: The present invention provides methods for inhibiting cancerous growth of a cell using an antibody or an antigen-binding portion thereof which binds to an epitope of EphB4 polypeptide. Purified antibodies of EphB4 are also provided. The invention also provides methods for preventing or treating cancer. The invention also relates to methods of identifying agents that can inhibit cancerous growth of a cell.
    Type: Grant
    Filed: September 16, 2003
    Date of Patent: May 25, 2010
    Assignee: The Queen Elizabeth Hospital Research Foundation, Inc.
    Inventor: Sally-Anne Stephenson
  • Patent number: 7455970
    Abstract: The present invention relates to a method of identifying a subject predisposed to ischemic stroke. The method includes the step of identifying a mutation in the subject that reduces the release rate of tissue plasminogen activator.
    Type: Grant
    Filed: July 2, 2004
    Date of Patent: November 25, 2008
    Assignees: The Queen Elizabeth Hospital Research Foundation Inc., Adelaide Research & Innovation Pty Ltd
    Inventors: Jim Jannes, Monica Anne Hamilton-Bruce, Simon Koblar
  • Publication number: 20080241824
    Abstract: The present invention relates to a method of identifying a subject predisposed to lacunar stroke. The method includes the step of identifying in the subject the presence of a thymine to cytosine mutation at position -107 in both alleles of the paraoxonase 1 locus.
    Type: Application
    Filed: February 18, 2005
    Publication date: October 2, 2008
    Applicants: THE QUEEN ELIZABETH HOSPITAL RESEARCH FOUNDATION INC., Adelaide Research & Innovation Pty Ltd.
    Inventors: Jim Jannes, Monica Anne Hamilton-Bruce, Simon Koblar
  • Publication number: 20070105110
    Abstract: The present invention relates to a method of identifying a subject predisposed to ischemic stroke. The method includes the step of identifying a mutation in the subject that reduces the release rate of tissue plasminogen activator.
    Type: Application
    Filed: July 2, 2004
    Publication date: May 10, 2007
    Applicants: THE QUEEN ELIZABETH HOSPITAL RESEARCH FOUNDATION INC., Adelaide Research & Innovation Pty Ltd.
    Inventors: Jim Jannes, Monica Hamilton-Bruce, Simon Koblar
  • Publication number: 20060134118
    Abstract: The present invention provides methods for inhibiting cancerous growth of a cell using an antibody or an antigen-binding portion thereof which binds to an epitope of EphB4 polypeptide. Purified antibodies of EphB4 are also provided. The invention also provides methods for preventing or treating cancer. The invention also relates to methods of identifying agents that can inhibit cancerous growth of a cell.
    Type: Application
    Filed: September 16, 2003
    Publication date: June 22, 2006
    Applicant: The Queen Elizabeth Hospital Research Foundation Inc.
    Inventor: Sally-Anne Stephenson
  • Publication number: 20050143463
    Abstract: The present invention relates to a method of inhibiting endothelial cell proliferation in a biological system, the method including the step of administering to the biological system an effective amount of an alkyl-substituted fatty acid, wherein the alkyl-substituted fatty acid is capable of inhibiting endothelial cell proliferation.
    Type: Application
    Filed: November 3, 2004
    Publication date: June 30, 2005
    Applicant: THE QUEEN ELIZABETH HOSPITAL RESEARCH FOUNDATION INC.
    Inventor: Ravi Krishnan